Does PEXIDARTINIB Cause Off label use? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Off label use have been filed in association with PEXIDARTINIB (Turalio). This represents 13.4% of all adverse event reports for PEXIDARTINIB.
130
Reports of Off label use with PEXIDARTINIB
13.4%
of all PEXIDARTINIB reports
6
Deaths
16
Hospitalizations
How Dangerous Is Off label use From PEXIDARTINIB?
Of the 130 reports, 6 (4.6%) resulted in death, 16 (12.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEXIDARTINIB. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does PEXIDARTINIB Cause?
Fatigue (378)
Product dose omission issue (335)
Hair colour changes (327)
Nausea (213)
Pruritus (186)
Aspartate aminotransferase increased (134)
Rash (131)
Alanine aminotransferase increased (124)
Diarrhoea (106)
Headache (103)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PEXIDARTINIB Alternatives Have Lower Off label use Risk?
PEXIDARTINIB vs PHENACETIN
PEXIDARTINIB vs PHENAZOPYRIDINE
PEXIDARTINIB vs PHENCYCLIDINE
PEXIDARTINIB vs PHENELZINE
PEXIDARTINIB vs PHENOBARBITAL